Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis

Kwag, D; Cho, BS; Bang, SY; Lee, JH; Min, GJ; Park, SS; Park, S; Yoon, JH; Lee, SE; Eom, KS; Kim, YJ; Lee, SK; Min, CK; Cho, SG; Lee, JW; Kim, HJ

Cho, BS (通讯作者)，Catholic Univ Korea, Catholic Hematol Hosp, Seoul St Marys Hosp, Coll Med,Dept Hematol, Seoul, South Korea.;Cho, BS (通讯作者)，Catholic Univ Korea, Leukemia Res Inst, Coll Med, Seoul, South Korea.

BLOOD CANCER JOURNAL, 2022; 12 (12):

Abstract

Venetoclax (VEN) combined with azacitidine (AZA) or decitabine (DEC) has been approved for older adults with acute myeloid leukemia (AML) unfit for in......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索